A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell&#174;) at two dose levels in patients with Huntington&#39;s disease.

NestaCell (mesenchymal stem cells) - Cellavita Scientific Research

http://www.ncbi.nlm.nih.gov/pubmed/41188963

Cristiane Valverde Wenceslau; Eduardo Pagani; Irina Kerkis; Joyce Macedo Sanches Fernandes; Leandro Hideki Ynoue; Luciana Ferrara

Nov 5, 2025